BioSpace News Archive

Mercury Poisoning Treatment Market Drivers, Restraints and Opportunity to 2028

Mercury poisoning is serious public health issues caused due to consumption of mercury that leads to sudden illness and death.

August 19, 2021
·
5 min read
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs

Rafarma Pharmaceuticals, Inc.OTC:(RAFA) and one of the world’s largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed implementing a joint project to produce the most popular platinum-based chemotherapy drugs.

August 19, 2021
·
2 min read
Protein Engineering Market by Technology, Application, Trends and Growth Forecasts 2021 – 2028

Protein engineering is a protocol used for production of unnatural polypeptides, these are done through modifying the naturally found amino acid sequences.

August 19, 2021
·
4 min read
From $$7.70 Bn to $14.59 Billion, Personal Mobility Devices Market for Dramatic Expansion in Medical Devices Industry

Advancements in technology, surge in prevalence of chronic diseases, and rise in aging population drive the global personal mobility devices market growth.

August 19, 2021
·
3 min read
Single Cell Multi-Omics Market Size to Hit $13.90 Billion, Growing at 18.2% CAGR by 2030

Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders, and rise in disposable income in emerging economies

August 19, 2021
·
3 min read
AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib

AB Science SA (Euronext - FR0010557264 - AB) today announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib.

August 19, 2021
·
9 min read
FDA

Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients

Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and Drug Administration (FDA) has granted a public hearing to discuss Makena, the only FDA-approved treatment, along with its equivalent generics, to reduce preterm birth in indicated patients.

August 19, 2021
·
1 min read
Biotech Beach

PIH Health Good Samaritan Hospital Offers First-of-Its-Kind Treatment for Heart Disease

PIH Health Good Samaritan Hospital has a new treatment option available for patients with severely calcified coronary artery disease.

August 19, 2021
·
3 min read
Drug Development

NervGen Pharma Provides an Operational Update on Its Ongoing Phase 1 Clinical Trial and Reports Second Quarter 2021 Results

The second quarter of 2021 was pivotal for NervGen as we started our Phase 1 clinical trial with NVG-291.

August 19, 2021
·
10 min read
Deals

Merger Places Nation’s Largest Lab Equipment Reseller in Massachusetts

Massachusetts based Biodirect and Boston Microscopes along with California based BioSurplus today announced the completion of a merger to form Copia Scientific, to be based in Massachusetts.

August 19, 2021
·
2 min read